Skip to content

Medicus Pharma Ltd Sustainability Reports

Medicus Pharma Ltd. is a clinical-stage biotech and life sciences company focused on the clinical development of novel and disruptive therapeutic assets. Its primary programs include non-invasive treatments for basal cell carcinoma and clinical evaluation of therapies in the biopharmaceutical sector.

Sector: Manufacturing

Country: Canada

Exchange: Nasdaq

LEI: 984500563DE3E9558204

FIGI: BBG01JPD08P6

1 reports from 2024 to 2024